Pfizer (PFE), BioNTech SE (BNTX) Report Agreement with the U.K. for 30M Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Go back to Pfizer (PFE), BioNTech SE (BNTX) Report Agreement with the U.K. for 30M Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2| (NASDAQ: BNTX) | Delayed: 90.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.19 | 52 Week High | $ | |||
| Open | $90.19 | 52 Week Low | $ | |||
| Day High | $90.19 | P/E | N/A | |||
| Day Low | $90.19 | EPS | $ | |||
| Volume | 3,553 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.08 | 52 Week High | $37.39 | |||
| Open | $25.08 | 52 Week Low | $28.25 | |||
| Day High | $25.08 | P/E | 15.20 | |||
| Day Low | $25.08 | EPS | $1.65 | |||
| Volume | 305,685 | |||||

